SkinMedica Inc. said April 3 that it hired Mary Fisher as its new chief executive officer.
Previously, Fisher was chief operating officer for Acorda Therapeutics, a Hawthorne, N.Y.-based biotechnology company focused on treatments for central nervous system disorders.
Fisher has also served at Cephalon, Immunex and Boehringer Ingelheim. SkinMedica CEO Rex Bright will continue as president and member of the company’s board of directors.
SkinMedica, a privately held, Carlsbad-based company, develops biopharmaceuticals for the dermatology market.
, Heather Chambers